Drug Shortage Report for APO-RIVASTIGMINE
Report ID | 20900 |
Drug Identification Number | 02336715 |
Brand name | APO-RIVASTIGMINE |
Common or Proper name | RIVASTIGMINE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | RIVASTIGMINE |
Strength(s) | 1.5MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 BTL |
ATC code | N06DA |
ATC description | ANTI-DEMENTIA DRUGS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-10-20 |
Actual start date | 2017-10-16 |
Estimated end date | 2019-10-18 |
Actual end date | 2019-10-11 |
Shortage status | Resolved |
Updated date | 2019-10-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v38 | 2019-10-15 | French | Compare |
v37 | 2019-10-15 | English | Compare |
v36 | 2019-09-20 | French | Compare |
v35 | 2019-09-20 | English | Compare |
v34 | 2019-07-30 | French | Compare |
v33 | 2019-07-30 | English | Compare |
v32 | 2019-07-30 | French | Compare |
v31 | 2019-07-30 | English | Compare |
v30 | 2019-06-25 | French | Compare |
v29 | 2019-06-25 | English | Compare |
v28 | 2019-05-06 | French | Compare |
v27 | 2019-05-06 | English | Compare |
v26 | 2019-03-27 | French | Compare |
v25 | 2019-03-27 | English | Compare |
v24 | 2018-10-19 | French | Compare |
v23 | 2018-10-19 | English | Compare |
v22 | 2018-10-11 | French | Compare |
v21 | 2018-10-11 | English | Compare |
v20 | 2018-08-20 | French | Compare |
v19 | 2018-08-20 | English | Compare |